Therefore, by targeting both cellular cholesterol uptake and BCR-associated cholesterol synthesis, cellular cholesterol reduction and apoptosis can be achieved in resistant ABC DLBCL cell lines [94]. The gene discussed is BCR; the disease is diffuse large B-cell lymphoma.